Dyne Therapeutics Inc (NASDAQ: DYN) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 102.32M common shares owned by the public and among those 86.99M shares have been available to trade. The company’s stock has a 5-day price change of -19.04% and -61.09% over the past three months. DYN shares are trading -60.82% year to date (YTD), with the 12-month market performance down to -67.49% lower. […]
Dyne Therapeutics Inc (DYN): A Great Stock For Handling Current Market Conditions?
Citadel Advisors LLC recently announced the acquisition of new stake in Dyne Therapeutics Inc (NASDAQ:DYN). The institutional investor has increased its shareholding in the Healthcare company by 11.54% to 3.02 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 4.92% valued currently at $33.44 million. In addition, BlackRock […]
